Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 43: 731-735, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perry, P. J.
Right arrow Articles by Holman, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perry, P. J.
Right arrow Articles by Holman, T. L.
Related Collections
Right arrow Drug Monitoring and Toxicology
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1997;43:731-735.)
© 1997 American Association for Clinical Chemistry, Inc.

Articles

Detection of anabolic steroid administration: ratio of urinary testosterone to epitestosterone vs the ratio of urinary testosterone to luteinizing hormone

Paul J. Perry1,3,a, John H. MacIndoe2, William R. Yates1, Shane D. Scott3 and Timothy L. Holman1

1 Departments of Psychiatry and
2 Internal Medicine, College of Medicine, and
3 Department of Clinical Pharmacy, College of Pharmacy, University of Iowa, Iowa City, IA 52246
a Address correspondence to this author, at: S415 Pharmacy, University of Iowa, Iowa City, IA 52246. Fax 319-353-5646; e-mail paul-perry{at}uiowa.edu

Our goal in this study was to determine whether the urinary ratio of testosterone to luteinizing hormone (T/LH) as an indicator of exogenous anabolic steroid (AS) use is superior to the urinary ratio of testosterone to epitestosterone (T/E). After 2 weekly placebo injections, 19 subjects were given testosterone cypionate (TC) injections of 250 or 500 mg/week for 14 weeks followed by 14 weekly placebo injections. Patients were considered to have ceased taking TC if they tested negative 9 weeks after their last injection. For detection of illicit or supraphysiological TC (AS) use, the urinary T/E ratio of >=6 yielded a false-negative rate of 46% and a false-positive rate of 4%. However, a urinary T/LH ratio of >=30 produced a false-negative rate of only 24% and a false-positive rate of 13%. We conclude that the urinary T/LH ratio of >=30 is a more sensitive marker of AS use than the urinary T/E ratio of >=6 and remains sensitive for twice as long as urinary T/E.


Key Words: indexing terms: abused drugs • sports medicine • GC-MS • androgens • anabolic steroids






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.